EBITDA Margin (Annual)

EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues

Elanco Animal Health Incorporated (ELAN) had EBITDA Margin of 17.19% for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$4.44B
Net Income	$338.00M
Cost of Goods Sold	$2.00B
Gross Profit	$2.44B
Operating Expenses	$4.34B
Operating Income	$101.00M
Non-Operating Income/Expense	$387.00M
Pre-Tax Income	$488.00M
Normalized Pre-Tax Income	$488.00M
Income after Taxes	$338.00M
Income from Continuous Operations	$338.00M
Consolidated Net Income/Loss	$338.00M
Normalized Income after Taxes	$338.00M
EBIT	$101.00M
EBITDA	$763.00M
Weighted-Average Shares Outstanding (Basic)	494.00M
Weighted-Average Shares Outstanding (Diluted)	497.30M
Earnings per Share (EPS) (Basic)	$0.68
Earnings per Share (EPS) (Diluted)	$0.68
Balance Sheet Financials
Current Assets	$3.21B
Property, Plant, and Equipment	$993.00M
Long-Term Assets	$9.40B
Total Assets	$12.61B
Current Liabilities	$1.31B
Long-Term Debt	$4.28B
Long-Term Liabilities	$5.20B
Total Liabilities	$6.52B
Common Equity	$6.10B
Tangible Shareholders Equity	$-2.00B
Shareholders Equity	$6.10B
Common Shares Outstanding	494.45M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$541.00M
Cash Flow from Investing Activities	$1.16B
Cash Flow from Financial Activities	$-1.49B
Beginning Cash	$352.00M
End Cash	$468.00M
Increase/Decrease in Cash	$116.00M
Stock-Based Compensation	$55.00M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.44
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.41
Debt to Equity Ratio	0.71
Gross Margin	54.88%
Operating Margin	2.28%
EBIT Margin	2.28%
EBITDA Margin	17.19%
Pre-Tax Profit Margin	10.99%
Profit Margin	7.61%
Free Cash Flow	$394.00M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.35
Inventory Turnover	1.27
Receiveable Turnover	5.01
Days Sales in Receivables	72.85
Return on Equity	5.54%
Return on Tangible Equity	-16.91%
Return on Assets	2.68%
Return on Investments	3.26%
Book Value Per Share	$12.33
Free Cash Flow per Share	$0.79
Operating Cash Flow per Share	$1.09

Data from Zacks Investment Research, Inc.